Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial

Junjie Li, Zhihua Wang, Liangan Chen, Wenjun Zhang, Li Ma, Jiong Wu, G.Y. Liu, Yunfei Hou, Ke‐Da Yu, Gen‐Hong Di, Lihong Fan, Yun Jiang, Simon Jiang, Qian Liang, Yang Shen, Zhimin Shao